PRESS RELEASES More events are coming soon. Keyword Search Year: 20202019201820172016201520142013 03/19/20 Summary ToggleTRACON Pharmaceuticals Announces Appointment of Saundra Pelletier to Board of Directors Printer Friendly PDF Version 03/16/20 Summary ToggleTRACON Announces Submission of Request for Type B Meeting with FDA to Discuss Trial Design for ENVASARC: A Potential Pivotal Study of Envafolimab in Sarcoma Printer Friendly PDF Version 03/09/20 Summary ToggleSanten and TRACON Discontinue Development of DE-122 for Wet Age-Related Macular Degeneration Printer Friendly PDF Version 02/27/20 Summary ToggleTRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update Printer Friendly PDF Version 02/20/20 Summary ToggleTRACON to Report Fourth Quarter and Full Year 2019 Financial Results and Company Highlights on February 27, 2020 Printer Friendly PDF Version 02/07/20 Summary ToggleTRACON Pharmaceuticals Announces Change to Nasdaq Capital Market Printer Friendly PDF Version 12/20/19 Summary ToggleTRACON Pharmaceuticals, 3D Medicines and Jiangsu Alphamab Announce Partnership for Development of Subcutaneous PD-L1 Single-Domain Antibody in Soft Tissue Sarcoma Printer Friendly PDF Version 11/08/19 Summary ToggleTRACON Pharmaceuticals Announces Reverse Stock Split Printer Friendly PDF Version 11/05/19 Summary ToggleTRACON Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update Printer Friendly PDF Version 10/29/19 Summary ToggleTRACON to Report Third Quarter 2019 Company Highlights and Financial Results on November 5, 2019 Printer Friendly PDF Version Pagination First page First Previous page Previous … Page 2 Current page 3 Page 4 Page 5 … Next page Next Last page Last
